MIRAPHARM 22 (panax quinquefolius- red ginseng capsule United States - English - NLM (National Library of Medicine)

mirapharm 22 (panax quinquefolius- red ginseng capsule

mirapharm., inc. - stimulant - to help the treatment of incurable diseases, various cancer, symptoms of atopy as immunomodulator due to immune deficiency.

CEFUROXIME MILPHARM 250 Milligram Film Coated Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

cefuroxime milpharm 250 milligram film coated tablet

milpharm limited - cefuroxime axetil (amorphous) - film coated tablet - 250 milligram - cephalosporins and related substances - antibacterials for systemic use, second-generation cephalosporins - cefuroxime milpharm is indicated for the treatment of the infections listed below in adults and children from the age of 3 months • acute streptococcal tonsillitis and pharyngitis. • acute bacterial sinusitis. • acute otitis media. • acute exacerbations of chronic bronchitis. • cystitis. • pyelonephritis. • uncomplicated skin and soft tissue infections. • treatment of early lyme disease.

CEFUROXIME MILPHARM 500 Milligram Film Coated Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

cefuroxime milpharm 500 milligram film coated tablet

milpharm limited - cefuroxime axetil (amorphous) - film coated tablet - 500 milligram - cephalosporins and related substances - antibacterials for systemic use, second-generation cephalosporins - acute streptococcal tonsillitis and pharyngitis. acute bacterial sinusitis. acute otitis media. acute exacerbations of chronic bronchitis. cystitis. pyelonephritis. uncomplicated skin and soft tissue infections. treatment of early lyme disease.

Allopurinol Milpharm 100mg Tablets United Kingdom - English - myHealthbox

allopurinol milpharm 100mg tablets

milpharm limited - allopurinol - tablets - 100mg - preparations inhibiting uric acid production - it is indicated for reducing urate/uric acid formation in conditions where urate/uric acid deposition has already occurred (e.g. gouty arthritis, skin tophi, nephrolithiasis) or is a predictable clinical risk (e.g. treatment of malignancy potentially leading to acute uric acid nephropathy). the main clinical conditions where urate/uric acid deposition may occur are: idiopathic gout; uric acid lithiasis; acute uric acid nephropathy; neoplastic disease and myeloproliferative disease with high cell turnover rates, in which high urate levels occur either spontaneously, or after cytotoxic therapy; certain enzyme disorders which lead to overproduction of urate, for example: hypoxanthine-guanine phosphoribosyltransferase, including lesch-nyhan syndrome; glucose-6-phosphatase including glycogen storage disease; phosphoribosylpyrophosphate synthetase, phosphoribosylpyrophosphate amidotransferase; adenine phosphoribosyltransferase. allopurinol is indicated for management of 2,8-dihydroxyadenine (2,8-dha) renal stones

Allopurinol Milpharm 300mg Tablets United Kingdom - English - myHealthbox

allopurinol milpharm 300mg tablets

milpharm limited - allopurinol - tablets - 300mg - preparations inhibiting uric acid production - it is indicated for reducing urate/uric acid formation in conditions where urate/uric acid deposition has already occurred (e.g. gouty arthritis, skin tophi, nephrolithiasis) or is a predictable clinical risk (e.g. treatment of malignancy potentially leading to acute uric acid nephropathy). the main clinical conditions where urate/uric acid deposition may occur are: idiopathic gout; uric acid lithiasis; acute uric acid nephropathy; neoplastic disease and myeloproliferative disease with high cell turnover rates, in which high urate levels occur either spontaneously, or after cytotoxic therapy; certain enzyme disorders which lead to overproduction of urate, for example: hypoxanthine-guanine phosphoribosyltransferase, including lesch-nyhan syndrome; glucose-6-phosphatase including glycogen storage disease; phosphoribosylpyrophosphate synthetase, phosphoribosylpyrophosphate amidotransferase; adenine phosphoribosyltransferase. allopurinol is indicated for management of 2,8-dihydroxyadenine (2,8-dha) renal stones r

FLUCONAZOLE MILPHARM 150 Milligram Capsules Hard Ireland - English - HPRA (Health Products Regulatory Authority)

fluconazole milpharm 150 milligram capsules hard

milpharm limited - fluconazole - capsules hard - 150 milligram - triazole derivatives

FLUCONAZOLE MILPHARM 200 Milligram Capsules Hard Ireland - English - HPRA (Health Products Regulatory Authority)

fluconazole milpharm 200 milligram capsules hard

milpharm limited - fluconazole - capsules hard - 200 milligram - triazole derivatives

FLUCONAZOLE MILPHARM 50 Milligram Capsules Hard Ireland - English - HPRA (Health Products Regulatory Authority)

fluconazole milpharm 50 milligram capsules hard

milpharm limited - fluconazole - capsules hard - 50 milligram - triazole derivatives

ARIPIPRAZOLE MILPHARM 5 Milligram Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

aripiprazole milpharm 5 milligram tablets

milpharm limited - aripiprazole - tablets - 5 milligram - other antipsychotics - other antipsychotic - it is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older

ARIPIPRAZOLE MILPHARM 10 Milligram Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

aripiprazole milpharm 10 milligram tablets

milpharm limited - aripiprazole - tablets - 10 milligram - other antipsychotics - other antipsychotic - it is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older.